Analyst firms · H.C. Wainwright · ICPT
H.C. Wainwright ICPT price target and rating history
Intercept Pharmaceuticals Inc. (ICPT) · Health Care
H.C. Wainwright rates Intercept Pharmaceuticals Inc. (ICPT) Buy with a $19 price target, as of its latest action on Jul 13, 2023. It has published 3 rating actions on ICPT since August 2021, including 1 upgrade and 1 downgrade.
- Current rating
- Buy
- Price target
- $19
- Median target, all firms
- Too few
- Actions on ICPT
- 3
H.C. Wainwright price target on ICPT
Every H.C. Wainwright rating on ICPT
- Jul 13, 2023
- May 22, 2023
- Aug 2, 2021
Questions about H.C. Wainwright and ICPT
- What is H.C. Wainwright's price target for ICPT?
- H.C. Wainwright's latest stated price target for Intercept Pharmaceuticals Inc. (ICPT) is $19, from its action on Jul 13, 2023.
- What is H.C. Wainwright's rating on ICPT?
- H.C. Wainwright rates ICPT Buy, a bullish rating, as of Jul 13, 2023.
- When did H.C. Wainwright last change its view on ICPT?
- On Jul 13, 2023, H.C. Wainwright upgrades to Buy from Sell, price target $8 to $19.
All H.C. Wainwright ratingsICPT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.